Related Experiment Video
Updated: Jul 16, 2026

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Toxic trace metals in the mentally ill patients
1Department of Mental Health, Jos University Teaching Hospital.
Abstract:
Serum Cadmium and lead were measured in 61 in- and out-patients of the Mental Health Unit of a University Teaching Hospital. Diagnosis using the ICD-10 Criteria divided the patients into 21 Depressives, 20 Manic-depressive and 20 Schizophrenics. Twenty "healthy" individuals matched for age and sex were used as controls. The measurements of cadmium and lead were done on admission and at 3 and 7 weeks after the relevant treatment had been given. Serum zinc was also measured because of the interaction between zinc and these toxic metals. Measurement was with the Atomic Absorption Spectrophotometer. Results showed that cadmium was raised in depressives (p < 0.02) and reduced in mania patients (p < 0.01). Lead was increased in depressives (p < 0.01) and schizophrenics (p < 0.05) but not in mania patients. Serum zinc was reduced in all mental patients. Serum levels of the toxic metals of the mental patients tended to move towards the values of the control group with treatment.
More Related Videos
Related Concept Videos
The Periodic Table and Organismal Elements
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Hepatic Encephalopathy

